獸藥用單株抗體的全球市場：按動物類型、應用、最終用戶和地區分析、競爭形勢和預測（2023-2033）

Global Monoclonal Antibodies in Veterinary Health Market: Focus on Animal Type, Application, and End User, Regional Analysis, and Competitive Landscape - Analysis and Forecast, 2023-2033

出版日期: 2024年03月08日 | 出版商:

BIS Research | 英文 | 商品交期: 7-10個工作天內

價格

簡介目錄

本報告調查了全球獸藥單株抗體市場，並提供了市場概況、主要趨勢、法律制度、市場影響因素和市場機會分析、市場規模趨勢和預測，以及各個細分市場和地區的詳細資訊。彙編分析、競爭形勢、主要企業簡介等。

The report on the global monoclonal antibodies in veterinary health market provides a thorough analysis of the market, providing insights into current trends, a future impact assessment, patent filing trends, and regulatory requirements for the market. It explores the impact of key global events, identifies driving factors and challenges affecting market growth, and highlights growth opportunities.

It profiles key market players and their strategies for market dominance, including a competitive analysis. The report also examines regional segmentation, estimating market presence and performance across different geographical regions worldwide, and discusses potential investment opportunities for shareholders and investors.

This report focuses on nurturing a profound understanding of market dynamics and serves as a valuable resource for business ventures, entrepreneurs, and industries looking for detailed insights into the monoclonal antibodies in veterinary health market.

Market Segmentation:

Segmentation 1: by Application

Dermatology
Pain
Others

Segmentation 2: by Animal Type

Dog
Others

Segmentation 3: by End User

Veterinary Hospitals
Others

Segmentation 3: by Region

North America
Europe
Asia-Pacific
Latin America
Middle East and Africa

Key Questions Answered:

What are the major driving factors, opportunities, and restraints in the global monoclonal antibodies in veterinary health market?
How will the market evolve during the forecast period, and what are its future prospects?
What are the key players of the market and their key developmental strategies which pose them as the key players of the market?
How will the segments evolve during the forecast period?
Which segments hold a prominent market share and what factors are influencing their growth in the market?

Executive Summary

Scope of the Study

Research Methodology

1. Global Monoclonal Antibodies in Veterinary Health Market: Overview

1.1 Product Definition
1.2 Inclusion and Exclusion Criteria
1.3 Key Findings

2. Global Monoclonal Antibodies in Veterinary Health Market: Industry Analysis

2.1 Regulatory Requirements
2.2 Key Trends
2.3 Impact of COVID-19 on Global Monoclonal Antibodies in Veterinary Health Market

3. Global Monoclonal Antibodies in Veterinary Health Market: Market Dynamics

3.1 Overview
3.2 Impact Analysis
3.3 Market Drivers
3.4 Market Restraints
3.5 Market Opportunities

4. Global Monoclonal Antibodies in Veterinary Health Market (by Animal Type)

4.1 Overview
4.2 Growth-Share Matrix
4.3 Dog
4.4 Others

5. Global Monoclonal Antibodies in Veterinary Health Market (by Application)

5.1 Overview
5.2 Growth-Share Matrix
5.3 Dermatology
5.4 Pain
5.5 Others

6. Global Monoclonal Antibodies in Veterinary Health Market (by End User)

6.1 Overview
6.2 Growth-Share Matrix
6.3 Veterinary Hospitals
6.4 Others

7. Global Monoclonal Antibodies in Veterinary Health Market, (by Region)

7.1 Overview
7.2 North America Monoclonal Antibodies in Veterinary Health Market
- 7.2.1 Overview
- 7.2.2 Market Size and Forecast
  - 7.2.2.1 North America Monoclonal Antibodies in Veterinary Health Market, by Country
    - 7.2.2.1.1 U.S.
    - 7.2.2.1.2 Canada
7.3 Europe
- 7.3.1 Overview
- 7.3.2 Market Size and Forecast
  - 7.3.2.1 Europe Monoclonal Antibodies in Veterinary Health Market, by Country
    - 7.3.2.1.1 Germany
    - 7.3.2.1.2 U.K.
    - 7.3.2.1.3 France
    - 7.3.2.1.4 Italy
    - 7.3.2.1.5 Spain
    - 7.3.2.1.6 Rest of Europe
7.4 Asia-Pacific
- 7.4.1 Overview
- 7.4.2 Market Size and Forecast
  - 7.4.2.1 Asia-Pacific Monoclonal Antibodies in Veterinary Health Market, by Country
    - 7.4.2.1.1 China
    - 7.4.2.1.2 Japan
    - 7.4.2.1.3 India
    - 7.4.2.1.4 South Korea
    - 7.4.2.1.5 Australia and New Zealand
    - 7.4.2.1.6 Rest of Asia-Pacific
7.5 Latin America
- 7.5.1 Overview
- 7.5.2 Market Size and Forecast
  - 7.5.2.1 Latin America Monoclonal Antibodies in Veterinary Health Market, by Country
    - 7.5.2.1.1 Brazil
    - 7.5.2.1.2 Mexico
    - 7.5.2.1.3 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 Overview
- 7.6.2 Market Size and Forecast
  - 7.6.2.1 Middle East and Africa Monoclonal Antibodies in Veterinary Health Market, by Country
    - 7.6.2.1.1 U.A.E
    - 7.6.2.1.2 South Africa
    - 7.6.2.1.3 Rest-of-Middle East and Africa

8. Global Monoclonal Antibodies in Veterinary Health Market: Competitive Insights and Company Profiles

8.1 Global Monoclonal Antibodies in Veterinary Market Active Players Ecosystem
8.2 Key Strategies and Developments
- 8.2.1 Overview
- 8.2.2 Collaborations and Partnerships
- 8.2.3 Acquisitions and Mergers
- 8.2.4 Business Expansions
- 8.2.5 Product Launches
- 8.2.6 Funding
8.3 Company Profiles
- 8.3.1 Merck & Co, Inc.
  - 8.3.1.1 Company Overview
  - 8.3.1.2 Product Portfolio
  - 8.3.1.3 Financials
  - 8.3.1.4 Recent Developments
  - 8.3.1.5 Analyst View
- 8.3.2 Zoetis
- 8.3.3 Elanco
- 8.3.4 Boehringer Ingelheim GmbH
- 8.3.5 Virbac
- 8.3.6 Invetx
- 8.3.7 Indian Immunologicals Ltd.
- 8.3.8 Other Companies